Skip to main content
Livermore
Livermore
ZHEN

Aptus Capital Advisors, LLC

SEC CIK
0001664193
Latest filing
Aug 12, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Aptus Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
7,463
Value
$675.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Aptus Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,463$675.1K<0.1%−204−2.7%ReducedHolders
Q1 20267,667$614.0K<0.1%−4,450−36.7%ReducedHolders
Q4 202512,117$1.03M<0.1%+2,750+29.4%AddedHolders
Q3 20259,367$728.5K<0.1%−5,815−38.3%ReducedHolders
Q2 202515,182$1.19M<0.1%+4,796+46.2%AddedHolders
Q1 202510,386$752.7K<0.1%+385+3.8%AddedHolders
Q4 202410,001$740.3K<0.1%+2,052+25.8%AddedHolders
Q3 20247,949$524.6K<0.1%−222−2.7%ReducedHolders
Q2 20248,171$754.8K<0.1%+261+3.3%AddedHolders
Q1 20247,910$755.9K<0.1%+2,316+41.4%AddedHolders
Q4 20235,594$426.5K<0.1%−776−12.2%ReducedHolders
Q3 20236,370$441.3K<0.1%+2,587+68.4%AddedHolders
Q2 20233,783$356.9K<0.1%+155+4.3%AddedHolders
Q1 20233,628$300.1K<0.1%−371−9.3%ReducedHolders
Q4 20223,999$298.4K<0.1%−225−5.3%ReducedHolders
Q3 20224,224$349.0K<0.1%−363−7.9%ReducedHolders
Q2 20224,587$436.0K<0.1%+243+5.6%AddedHolders
Q1 20224,344$511.0K<0.1%−34,144−88.7%ReducedHolders
Q4 202138,488$4.99M0.2%+5,346+16.1%AddedHolders
Q3 202133,142$3.75M0.1%+2,664+8.7%AddedHolders
Q2 202130,478$3.16M0.1%−8,351−21.5%ReducedHolders
Q1 202138,829$3.25M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.